ARDELYX, INC. Fair Value of Assets Acquired
ARDELYX, INC. (ARDX) reported Fair Value of Assets Acquired of $134.00 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueOfAssetsAcquired · last filed 2015-08-12
- ARDELYX, INC. fair value of assets acquired for the quarter ending 2015-06-30 was -$100.00K.
- ARDELYX, INC. fair value of assets acquired for the quarter ending 2015-03-31 was $234.00K.
| Period end | Fair Value of Assets Acquired 3 month | Fair Value of Assets Acquired 6 month |
|---|---|---|
| 2015-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $134.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $234.00K 10-Q · filed 2015-05-12 | |
| 2014-06-30 | $499.00K 10-Q · filed 2015-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |